Pharmacokinetics of ceftriaxone in pediatric patients with meningitis. 1983

R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler

Pharmacokinetics of ceftriaxone after a single dose of 50 or 75 mg/kg were determined in 30 pediatric patients with bacterial meningitis. Data for doses of 50 and 75 mg/kg, respectively, were as follows (mean +/- standard deviation): maximum plasma concentrations, 230 +/- 64 and 295 +/- 76 mug/ml; elimination rate constant, 0.14 +/- 0.06 and 0.14 +/- 0.04 h(-1); harmonic elimination half-life, 5.8 +/- 2.8 and 5.4 +/- 2.1 h; plasma clearance, 51 +/- 24 and 55 +/- 18 ml/h per kg; volume of distribution, 382 +/- 129 and 387 +/- 56 ml/kg; mean concentration in cerebrospinal fluid 1 to 6 h after infusion, 5.4 and 6.4 mug/ml. A dosage schedule of 50 mg/kg every 12 h for bacterial meningitis caused by susceptible organisms is suggested for pediatric patients over 7 days of age.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
October 1982, Antimicrobial agents and chemotherapy,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
September 1984, The Journal of pediatrics,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
October 2023, European journal of pediatrics,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
January 1983, The Journal of pediatrics,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
October 1994, Antimicrobial agents and chemotherapy,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
July 1989, Journal of chemotherapy (Florence, Italy),
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
February 1988, The Japanese journal of antibiotics,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
December 2023, Therapeutic drug monitoring,
R W Steele, and L B Eyre, and R W Bradsher, and R E Weinfeld, and I H Patel, and J Spicehandler
November 1983, American journal of diseases of children (1960),
Copied contents to your clipboard!